Re: Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

Donald L. Lamm

doi:10.1016/j.eururo.2011.03.040

Re: Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

European Urology ◽

10.1016/j.eururo.2011.03.040 ◽

2011 ◽

Vol 59 (6) ◽

pp. 1065

Author(s):

Donald L. Lamm

Keyword(s):

High Risk ◽

Urothelial Carcinoma ◽

Bacillus Calmette Guerin ◽

Phase 3 ◽

Term Efficacy ◽

Carcinoma Of The Bladder ◽

Intravesical Instillations

Download Full-text

Re: Richard J. Sylvester, Maurizio A. Brausi, Wim J. Kirkels, et al. Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder. Eur Urol 2010;57:766–73

European Urology ◽

10.1016/j.eururo.2010.02.037 ◽

2010 ◽

Vol 57 (6) ◽

pp. e57

Author(s):

Tommaso Cai ◽

Lorenzo Giuseppe Luciani ◽

Gianni Malossini

Keyword(s):

High Risk ◽

Urothelial Carcinoma ◽

Bacillus Calmette Guerin ◽

Phase 3 ◽

Term Efficacy ◽

Carcinoma Of The Bladder ◽

Intravesical Instillations

Download Full-text

Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

European Urology ◽

10.1016/j.eururo.2009.12.024 ◽

2010 ◽

Vol 57 (5) ◽

pp. 766-773 ◽

Cited By ~ 225

Author(s):

Richard J. Sylvester ◽

Maurizio A. Brausi ◽

Wim J. Kirkels ◽

Wolfgang Hoeltl ◽

Fernando Calais Da Silva ◽

...

Keyword(s):

High Risk ◽

Urothelial Carcinoma ◽

Bacillus Calmette Guerin ◽

Phase 3 ◽

Term Efficacy ◽

Carcinoma Of The Bladder ◽

Intravesical Instillations

Download Full-text

Long-term efficacy results of EORTC Genito-Urinary Group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder

International braz j urol ◽

10.1590/s1677-55382010000400024 ◽

2010 ◽

Vol 36 (4) ◽

pp. 504-517

Author(s):

Andreas Bohle

Keyword(s):

High Risk ◽

Urothelial Carcinoma ◽

Bacillus Calmette Guerin ◽

Phase 3 ◽

Term Efficacy ◽

Carcinoma Of The Bladder ◽

Intravesical Instillations

Download Full-text

Reply to Tomasso Cai, Lorenzo Giuseppe Luciani and Gianni Malossini’s Letter to the Editor re: Richard J. Sylvester, Maurizio A. Brausi, Wim J. Kirkels, et al. Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder. Eur Urol 2010;57:766–73

European Urology ◽

10.1016/j.eururo.2010.02.038 ◽

2010 ◽

Vol 57 (6) ◽

pp. e58-e59

Author(s):

Richard J. Sylvester ◽

Maurizio A. Brausi ◽

Ziya Kirkali ◽

Theo M. de Reijke

Keyword(s):

High Risk ◽

Urothelial Carcinoma ◽

Bacillus Calmette Guerin ◽

Phase 3 ◽

Term Efficacy ◽

Letter To The Editor ◽

Carcinoma Of The Bladder ◽

Intravesical Instillations

Download Full-text